Merck (MRK) Long-Term Debt Repayments (2009 - 2026)

Merck (MRK) has 17 years of Long-Term Debt Repayments data on file, last reported at $1.1 billion in Q1 2026.

• Long-Term Debt Repayments for Q1 2026 came in at $1.1 billion, down 54.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 62.39% YoY), and the FY2025 annual result was $2.5 billion, up 94.03% from the prior year.
• Long-Term Debt Repayments climbed to $1.1 billion in Q1 2026 per MRK's latest filing, from $2.0 million in the prior quarter.
• Over five years, Long-Term Debt Repayments peaked at $2.5 billion in Q1 2025 and troughed at $1.0 million in Q4 2022.
• A 5-year average of $687.6 million and a median of $539.0 million in 2024 frame the typical range for Long-Term Debt Repayments.
• The sharpest annual moves came in 2023 and 2024: Long-Term Debt Repayments tumbled 99.92% in 2023, then jumped 75000.0% in 2024.
• A 5-year view of Long-Term Debt Repayments shows it stood at $1.0 million in 2022, then jumped by 200.0% to $3.0 million in 2023, then soared by 17866.67% to $539.0 million in 2024, then tumbled by 99.63% to $2.0 million in 2025, then surged by 56900.0% to $1.1 billion in 2026.
• Business Quant data shows MRK's Long-Term Debt Repayments at $1.1 billion in Q1 2026, $2.0 million in Q4 2025, and $1.0 million in Q3 2025.